Genetic-disease and oncology drug developer
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| Ancora | 38 | New buy | 100 | $7,426 | 0.0% |
| Bridgewater | 49 | Added +501% | 259,459 | $19,267,425 | 0.1% |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-06-27.